In particular, estrogen not only plays an important part in the physiological functioning of breast tissue, but also plays a causal role in the manifestation of breast cancer, as evidenced by the use of ER blockers (ERBs) as therapeutic agents in a few subtypes of breast cancer which are termed as receptor-positive subtypes (for breast cancer overview please refer [85,86]). Here, ESR1 is linked to breast cancer.